Your browser doesn't support javascript.
loading
The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T-cell-dependent tumor immunity.
Mangsbo, Sara M; Broos, Sissela; Fletcher, Erika; Veitonmäki, Niina; Furebring, Christina; Dahlén, Eva; Norlén, Per; Lindstedt, Malin; Tötterman, Thomas H; Ellmark, Peter.
Affiliation
  • Mangsbo SM; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.
  • Broos S; Department of Immunotechnology, Lund University, Lund, Sweden.
  • Fletcher E; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.
  • Veitonmäki N; Alligator Bioscience AB, Lund, Sweden.
  • Furebring C; Alligator Bioscience AB, Lund, Sweden.
  • Dahlén E; Alligator Bioscience AB, Lund, Sweden.
  • Norlén P; Alligator Bioscience AB, Lund, Sweden.
  • Lindstedt M; Department of Immunotechnology, Lund University, Lund, Sweden.
  • Tötterman TH; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.
  • Ellmark P; Department of Immunotechnology, Lund University, Lund, Sweden. Alligator Bioscience AB, Lund, Sweden. pek@alligatorbioscience.com.
Clin Cancer Res ; 21(5): 1115-26, 2015 Mar 01.
Article in En | MEDLINE | ID: mdl-25316820

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / T-Lymphocytes / CD40 Antigens / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Prognostic_studies Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country: Sweden Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / T-Lymphocytes / CD40 Antigens / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Prognostic_studies Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country: Sweden Country of publication: United States